What are the International Consensus Report recommendations for quality of life assessment in children with immune thrombocytopenia (ITP)?

Updated: Jan 11, 2020
  • Author: Craig M Kessler, MD, MACP; Chief Editor: Srikanth Nagalla, MBBS, MS, FACP  more...
  • Print

Health-related quality of life considerations:

  • HRQoL should be reported using the Kid’s ITP Tool (KIT) or another validated scale before and after treatment, to assess the effect of treatment beyond the platelet count.
  • Corticosteroids may worsen HRQoL in children with ITP; TPO-RAs may improve their HRQoL, and romiplostim especially appears to improve parental burden.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!